Qube Research & Technologies Ltd

SEC CIK: 0001729829
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

MGX holding history

Metagenomi Therapeutics, Inc. in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MGX overview All 13F holders of MGX Full Q2 2026 holdings

Shares (Q2 2026): 16,850
Value: $20.1K
% of portfolio: <0.1%
Quarters held: 3; Since Q1 2024

Holdings of MGX by Qube Research & Technologies Ltd, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	16,850	$20.1K	<0.1%	+16,850	New	Holders
Q3 2024	0	$0	0.0%	−1,053−100.0%	Sold out	Holders
Q2 2024	1,053	$4.30K	<0.1%	−15,614−93.7%	Reduced	Holders
Q1 2024	16,667	$175.8K	<0.1%	+16,667	New	Holders